{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:41:21Z","timestamp":1792626081169,"version":"4.5.0"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejmech.2021.113471","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T05:51:35Z","timestamp":1618984295000},"page":"113471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Overview of piperlongumine analogues and their therapeutic potential"],"prefix":"10.1016","volume":"220","author":[{"given":"Peng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fansheng","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113471_bib1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/np100550t","article-title":"Modern natural products drug discovery and its relevance to biodiversity conservation","volume":"74","author":"Kingston","year":"2011","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113471_bib2","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1021\/jm0704090","article-title":"Natural products as leads to potential drugs: an old process or the new hope for drug discovery?","volume":"51","author":"Newman","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113471_bib3","first-page":"33","article-title":"Mother Nature\u2019s gifts to diseases of man: the impact of natural products on anti-infective, anticholestemics and anticancer drug discovery","volume":"65","author":"Butler","year":"2008","journal-title":"Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques"},{"key":"10.1016\/j.ejmech.2021.113471_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nchem.2479","article-title":"Counting on natural products for drug design","volume":"8","author":"Rodrigues","year":"2016","journal-title":"Nat. Chem."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.ejmech.2021.113471_bib5","article-title":"The role of natural products in modern drug discovery","volume":"91","author":"Calixto","year":"2019","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.ejmech.2021.113471_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jep.2005.05.011","article-title":"Plants as a source of anti-cancer agents","volume":"100","author":"Cragg","year":"2005","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113471_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-8741(97)00037-8","article-title":"Management of giardiasis by a herbal drug \u2019Pippali Rasayana\u2019: a clinical study","volume":"56","author":"Agarwal","year":"1997","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113471_bib8","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0968-0896(97)00091-6","article-title":"Anti-invasive activity of alkaloids and polyphenolics in\u00a0vitro","volume":"5","author":"Parmar","year":"1997","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.phymed.2007.06.011","article-title":"Antiplatelet effects of acidamides isolated from the fruits of Piper longum L","volume":"14","author":"Park","year":"2007","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2021.113471_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/10286020.2010.546789","article-title":"Two new amides with cytotoxic activity from the fruits of Piper longum","volume":"13","author":"Mishra","year":"2011","journal-title":"J.\u00a0Asian Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib11","first-page":"1","article-title":"Chemical constituents from the fruits of Piper longum L. and their vascular relaxation effect on rat mesenteric arteries","author":"Li","year":"2020","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1211\/jpp.61.04.0014","article-title":"Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: possible involvement of cyclooxygenase blockade and antioxidant activity","volume":"61","author":"Fontenele","year":"2009","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113471_bib13","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0040-4020(01)82575-8","article-title":"Alkaloids of Piper longum Linn. I. Structure and synthesis of piperlongumine and piperlonguminine","volume":"23","author":"Chatterjee","year":"1967","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113471_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejps.2012.12.003","article-title":"Overview of the therapeutic potential of piplartine (piperlongumine)","volume":"48","author":"Bezerra","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2021.113471_bib15","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.tiv.2009.05.023","article-title":"Diferuloylmethane augments the cytotoxic effects of piplartine isolated from Piper chaba","volume":"23","author":"Jyothi","year":"2009","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2021.113471_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-9422(97)00328-2","article-title":"Phytochemistry of the genus piper","volume":"46","author":"Parmar","year":"1997","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2021.113471_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-2005-864155","article-title":"New cytotoxic cyclobutanoid amides, a new furanoid lignan and anti-platelet aggregation constituents from Piper arborescens","volume":"71","author":"Tsai","year":"2005","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2021.113471_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jep.2003.10.016","article-title":"Immunomodulatory and antitumor activity of Piper longum Linn. and piperine","volume":"90","author":"Sunila","year":"2004","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113471_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1590\/S0100-879X2006000600014","article-title":"In\u00a0vivo growth-inhibition of Sarcoma 180 by piplartine and piperine, two alkaloid amides from Piper, Braz","volume":"39","author":"Bezerra","year":"2006","journal-title":"J.\u00a0Med. Biol. Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2018.06.057","article-title":"Piperlongumine (piplartine) as a lead compound for anticancer agents - synthesis and properties of analogues: a mini-review","volume":"156","author":"Piska","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib21","doi-asserted-by":"crossref","first-page":"104772","DOI":"10.1016\/j.phrs.2020.104772","article-title":"Piperlongumine, a potent anticancer phytotherapeutic: perspectives on contemporary status and future possibilities as an anticancer agent","volume":"156","author":"Tripathi","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrcardio.2017.206","article-title":"Current and future antiplatelet therapies: emphasis on preserving haemostasis","volume":"15","author":"McFadyen","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejmech.2021.113471_bib23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbrc.2012.09.061","article-title":"Piperlongumine inhibits atherosclerotic plaque formation and vascular smooth muscle cell proliferation by suppressing PDGF receptor signaling","volume":"427","author":"Son","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113471_bib24","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ptr.2432","article-title":"Antiplatelet activities of newly synthesized derivatives of piperlongumine","volume":"22","author":"Park","year":"2008","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib25","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/cbdd.12714","article-title":"Design, synthesis and pharmacological evaluation of novel piperlongumine derivatives as potential antiplatelet aggregation candidate","volume":"87","author":"Wang","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2021.113471_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/1389557517666161111110121","article-title":"Recent highlights on molecular hybrids potentially useful in central nervous system disorders","volume":"17","author":"Matias","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejmech.2017.07.081","article-title":"Piperlongumine B and analogs are promising and selective inhibitors for acetylcholinesterase","volume":"139","author":"Wiemann","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib28","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s12272-001-1275-5","article-title":"Neuroprotective effect of benzylideneacetophenone derivative on the MPTP model of neurodegeneration in mice","volume":"31","author":"Kang","year":"2008","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2021.113471_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/cbdd.12087","article-title":"Synthesis and evaluation of a series of 3,4,5-trimethoxycinnamic acid derivatives as potential antinarcotic agents","volume":"81","author":"Jung","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2021.113471_bib30","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00044-012-0415-1","article-title":"A\u00a0simple synthesis of trans-3,4,5-trimethoxycinnamamides and evaluation of their biologic activity","volume":"22","author":"Jung","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib31","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10072-013-1618-z","article-title":"Cinepazide maleate protects PC12 cells against oxygen-glucose deprivation-induced injury","volume":"35","author":"Zhao","year":"2014","journal-title":"Neurol. Sci. : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"key":"10.1016\/j.ejmech.2021.113471_bib32","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1021\/acs.jmedchem.5b00410","article-title":"Synthesis of piperlongumine analogues and discovery of nuclear factor erythroid 2-related factor 2 (Nrf2) activators as potential neuroprotective agents","volume":"58","author":"Peng","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib33","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1021\/acschemneuro.9b00402","article-title":"Design and green synthesis of piperlongumine analogs and their antioxidant activity against cerebral ischemia-reperfusion injury","volume":"10","author":"Li","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113471_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/13543776.2019.1582646","article-title":"Aldose reductase inhibitors: 2013-present","volume":"29","author":"Quattrini","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.113471_bib35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113471_bib36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ejmech.2012.09.014","article-title":"Synthesis and biological evaluation of new piplartine analogues as potent aldose reductase inhibitors (ARIs)","volume":"57","author":"Rao","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib37","doi-asserted-by":"crossref","first-page":"101896","DOI":"10.1016\/j.pupt.2020.101896","article-title":"Effect of piperlongumine during exposure to cigarette smoke reduces inflammation and lung injury","volume":"61","author":"Sant\u2019Ana","year":"2020","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113471_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejmech.2021.113471_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00011-017-1112-9","article-title":"Piperlongumine inhibits the proliferation, migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"67","author":"Xu","year":"2018","journal-title":"Inflamm. Res. : official journal of the European Histamine Research Society"},{"key":"10.1016\/j.ejmech.2021.113471_bib40","first-page":"1213","article-title":"Piperlongumine attenuates il-1\u03b2-induced inflammatory response in chondrocytes","volume":"29","author":"Hu","year":"2018","journal-title":"Biomed. Res. (India)"},{"key":"10.1016\/j.ejmech.2021.113471_bib41","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1016\/j.bmcl.2015.07.079","article-title":"Vascular barrier protective effects of 3-N- or 3-O-cinnamoyl carbazole derivatives","volume":"25","author":"Ku","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113471_bib42","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1016\/j.bmcl.2014.10.054","article-title":"Synthesis and biological evaluation of piperlongumine derivatives as potent anti-inflammatory agents","volume":"24","author":"Seo","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113471_bib43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bcp.2015.03.014","article-title":"Development and mechanism investigation of a new piperlongumine derivative as a potent anti-inflammatory agent","volume":"95","author":"Sun","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113471_bib44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejmech.2019.07.020","article-title":"Synthesis and assessment of phenylacrylamide derivatives as potential anti-oxidant and anti-inflammatory agents","volume":"180","author":"Gu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib45","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1111\/jgs.14969","article-title":"The clinical potential of senolytic drugs","volume":"65","author":"Kirkland","year":"2017","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113471_bib46","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/joim.13141","article-title":"Senolytic drugs: from discovery to translation","volume":"288","author":"Kirkland","year":"2020","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.ejmech.2021.113471_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.08.006","article-title":"Senescence and senotherapeutics: a new field in cancer therapy","volume":"193","author":"Myrianthopoulos","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113471_bib48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113471_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.redox.2016.11.005","article-title":"Redox control of senescence and age-related disease","volume":"11","author":"Chandrasekaran","year":"2017","journal-title":"Redox biology"},{"key":"10.1016\/j.ejmech.2021.113471_bib50","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1016\/j.bmc.2018.06.013","article-title":"Senolytic activity of piperlongumine analogues: synthesis and biological evaluation","volume":"26","author":"Liu","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2013.01.017","article-title":"Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells","volume":"431","author":"Jarvius","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113471_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fnmol.2016.00004","article-title":"The ubiquitin-proteasome system: potential therapeutic targets for alzheimer\u2019s disease and spinal cord injury","volume":"9","author":"Gong","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113471_bib53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-pharmtox-010814-124727","article-title":"Structure-driven developments of 26S proteasome inhibitors","volume":"56","author":"Sledz","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113471_bib54","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bbrc.2018.01.100","article-title":"Piperlongumine and some of its analogs inhibit selectively the human immunoproteasome over the constitutive proteasome","volume":"496","author":"Bosc","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113471_bib55","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/ar700108g","article-title":"Targeted cancer therapy: conferring specificity to cytotoxic drugs","volume":"41","author":"Chari","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib56","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbrc.2013.06.012","article-title":"Piperlongumine inhibits LMP1\/MYC-dependent mouse B-lymphoma cells","volume":"436","author":"Han","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113471_bib57","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1021\/np50072a030","article-title":"Cytotoxic pyridone alkaloids from the leaves of piper-aborescens","volume":"53","author":"Duh","year":"1990","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113471_bib58","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/0031-9422(90)85215-2","article-title":"Cytotoxic pyridone alkaloids from piper-aborescens","volume":"29","author":"Duh","year":"1990","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2021.113471_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.fct.2017.10.058","article-title":"Piperlongumine decreases cell proliferation and the expression of cell cycle-associated proteins by inhibiting Akt pathway in human lung cancer cells","volume":"111","author":"Seok","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113471_bib60","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1515\/znc-2005-7-805","article-title":"Antiproliferative effects of two amides, piperine and piplartine, from piper species","volume":"60","author":"Bezerra","year":"2005","journal-title":"Z.\u00a0Naturforsch. C Biosci."},{"key":"10.1016\/j.ejmech.2021.113471_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2006.07.007","article-title":"Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways","volume":"21","author":"Bezerra","year":"2007","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2021.113471_bib62","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.21873\/anticanres.12978","article-title":"Piperlongumine induces apoptosis in colorectal cancer HCT 116 cells independent of bax, p21 and p53 status","volume":"38","author":"DA Silva Machado","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib63","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s10495-014-0991-2","article-title":"Piperlongumine, an alkaloid causes inhibition of PI3 K\/Akt\/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells","volume":"19","author":"Shrivastava","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2021.113471_bib64","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2013.06.042","article-title":"Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation","volume":"437","author":"Liu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113471_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pros.22739","article-title":"Piperlongumine inhibits NF-kappaB activity and attenuates aggressive growth characteristics of prostate cancer cells","volume":"74","author":"Ginzburg","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.ejmech.2021.113471_bib66","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2017-3250","article-title":"Computational drug repositioning and biochemical validation of piperlongumine as a potent therapeutic agent for neuroendocrine prostate cancer","volume":"77","author":"Yadav","year":"2017","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib67","article-title":"Piperlongumine suppresses proliferation of human oral squamous cell carcinoma through cell cycle arrest, apoptosis and senescence","volume":"17","author":"Chen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113471_bib68","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.3892\/mmr.2016.5091","article-title":"Piperlongumine inhibits gastric cancer cells via suppression of the JAK1,2\/STAT3 signaling pathway","volume":"13","author":"Song","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2021.113471_bib69","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/01635581.2018.1445769","article-title":"Piperlongumine induces apoptosis in human melanoma cells via reactive oxygen species mediated mitochondria disruption","volume":"70","author":"Song","year":"2018","journal-title":"Nutr. Canc."},{"key":"10.1016\/j.ejmech.2021.113471_bib70","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bst0290345","article-title":"Role of reactive oxygen species in cell signalling pathways","volume":"29","author":"Hancock","year":"2001","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2021.113471_bib71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.etap.2016.06.025","article-title":"ROS-mediated apoptosis of HAPI microglia through p53 signaling following PFOS exposure","volume":"46","author":"Ge","year":"2016","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113471_bib72","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/1573406414666180827112724","article-title":"Design, synthesis, and biological evaluation of novel thiazolyl substituted bis-pyrazole oxime derivatives with potent antitumor activities by selectively inducing apoptosis and ROS in cancer cells","volume":"15","author":"Xiong","year":"2019","journal-title":"Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113471_bib73","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.7150\/thno.56747","article-title":"The double-edged roles of ROS in cancer prevention and therapy","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2021.113471_bib74","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20130282","article-title":"ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors","volume":"454","author":"Halasi","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.113471_bib75","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2016.02.058","article-title":"Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer","volume":"375","author":"Zou","year":"2016","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2021.113471_bib76","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1940-6207.CAPR-17-0053","article-title":"Piperlongumine induces Reactive Oxygen Species (ROS)-dependent downregulation of specificity protein transcription factors","volume":"10","author":"Karki","year":"2017","journal-title":"Canc. Prev. Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib77","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1038\/s41388-017-0110-2","article-title":"Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1","volume":"37","author":"Hang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113471_bib78","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2019.02.034","article-title":"Piperlongumine increases sensitivity of colorectal cancer cells to radiation: involvement of ROS production via dual inhibition of glutathione and thioredoxin systems","volume":"450","author":"Wang","year":"2019","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2021.113471_bib79","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2012-LB-181","article-title":"Piperlongumine inhibits growth and survival of human Burkitt lymphoma by downregulating NF-{kappa}B, c-Myc and LMP1","volume":"72","author":"Han","year":"2012","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib80","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.leukres.2012.11.009","article-title":"Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in\u00a0vitro","volume":"37","author":"Han","year":"2013","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113471_bib81","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbrc.2013.06.012","article-title":"Piperlongumine inhibits LMP1\/MYC-dependent mouse B-lymphoma cells","volume":"436","author":"Han","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113471_bib82","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2013-5115","article-title":"Inhibition of STAT-3 by piperlongumine induces anoikis in melanoma cells in\u00a0vitro and blocks tumor formation potential in\u00a0vivo","volume":"73","author":"Fofaria","year":"2013","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib83","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/onc.2014.72","article-title":"Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer","volume":"34","author":"Bharadwaj","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113471_bib84","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2015.05.016","article-title":"Piperlongumine is a novel nuclear export inhibitor with potent anticancer activity","volume":"237","author":"Niu","year":"2015","journal-title":"Chem.Bio. Interact."},{"key":"10.1016\/j.ejmech.2021.113471_bib85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/pros.22535","article-title":"Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells","volume":"73","author":"Golovine","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.ejmech.2021.113471_bib86","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.7314\/APJCP.2014.15.7.3211","article-title":"Radio-sensitization by piper longumine of human breast adenoma MDA-MB-231 cells in\u00a0vitro","volume":"15","author":"Yao","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.ejmech.2021.113471_bib87","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s10495-014-0991-2","article-title":"Piperlongumine, an alkaloid causes inhibition of PI3 K\/Akt\/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells","volume":"19","author":"Shrivastava","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2021.113471_bib88","doi-asserted-by":"crossref","first-page":"906804","DOI":"10.1155\/2014\/906804","article-title":"Piperlongumine induces apoptosis and synergizes with cisplatin or paclitaxel in human ovarian cancer cells","volume":"2014","author":"Gong","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2021.113471_bib89","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bbrc.2014.08.131","article-title":"Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance","volume":"452","author":"Han","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113471_bib90","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/neuonc\/nou088","article-title":"Piperlongumine treatment inactivates peroxiredoxin 4, exacerbates endoplasmic reticulum stress, and preferentially kills high-grade glioma cells","volume":"16","author":"Kim","year":"2014","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2021.113471_bib91","doi-asserted-by":"crossref","first-page":"653732","DOI":"10.1155\/2014\/653732","article-title":"Piperlongumine inhibits migration of glioblastoma cells via activation of ROS-dependent p38 and JNK signaling pathways","volume":"2014","author":"Liu","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2021.113471_bib92","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/bjc.2013.810","article-title":"Piperlongumine promotes autophagy via inhibition of Akt\/mTOR signalling and mediates cancer cell death","volume":"110","author":"Makhov","year":"2014","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113471_bib93","doi-asserted-by":"crossref","first-page":"327","DOI":"10.14348\/molcells.2015.2235","article-title":"Heme oxygenase-1 determines the differential response of breast cancer and normal cells to piperlongumine","volume":"38","author":"Lee","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2021.113471_bib94","article-title":"Piperlongumine and immune cytokine TRAIL synergize to promote tumor death","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113471_bib95","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0394632015598849","article-title":"Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K\/Akt\/mTOR pathway","volume":"28","author":"Wang","year":"2015","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113471_bib96","article-title":"Piperlongumine inhibits lung tumor growth via inhibition of nuclear factor kappa B signaling pathway","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113471_bib97","doi-asserted-by":"crossref","first-page":"40531","DOI":"10.18632\/oncotarget.9643","article-title":"Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models","volume":"7","author":"Bullova","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113471_bib98","doi-asserted-by":"crossref","first-page":"10793","DOI":"10.1007\/s13277-016-4792-9","article-title":"Piperlongumine induces gastric cancer cell apoptosis and G2\/M cell cycle arrest both in\u00a0vitro and in\u00a0vivo","volume":"37","author":"Duan","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ejmech.2021.113471_bib99","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10495-017-1422-y","article-title":"Piperlongumine induces G2\/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway","volume":"22","author":"Thongsom","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2021.113471_bib100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbrc.2017.10.061","article-title":"Piperlongumine suppresses bladder cancer invasion via inhibiting epithelial mesenchymal transition and F-actin reorganization","volume":"494","author":"Liu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113471_bib101","first-page":"1011","article-title":"Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis","volume":"52","author":"Yamaguchi","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2021.113471_bib102","first-page":"1423","article-title":"Piperlongumine induces apoptosis and autophagy in leukemic cells through targeting the PI3K\/Akt\/mTOR and p38 signaling pathways","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2021.113471_bib103","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/01635581.2018.1445769","article-title":"Piperlongumine induces apoptosis in human melanoma cells via reactive oxygen species mediated mitochondria disruption","volume":"70","author":"Song","year":"2018","journal-title":"Nutr. Canc."},{"key":"10.1016\/j.ejmech.2021.113471_bib104","first-page":"1687","article-title":"Piperlongumine induces autophagy in biliary cancer cells via reactive oxygen species-activated Erk signaling pathway","volume":"44","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113471_bib105","doi-asserted-by":"crossref","first-page":"104775","DOI":"10.1016\/j.tiv.2020.104775","article-title":"Piperlongumine induces apoptosis and G2\/M phase arrest in human osteosarcoma cells by regulating ROS\/PI3K\/Akt pathway","volume":"65","author":"Zhou","year":"2020","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2021.113471_bib106","doi-asserted-by":"crossref","first-page":"15115","DOI":"10.1073\/pnas.1212802109","article-title":"Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs","volume":"109","author":"Adams","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.113471_bib107","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2016.05.021","article-title":"Designing piperlongumine-directed anticancer agents by an electrophilicity-based prooxidant strategy: a mechanistic investigation","volume":"97","author":"Yan","year":"2016","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113471_bib108","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1021\/acs.jmedchem.6b00772","article-title":"Synthesis and antileukemic activities of piperlongumine and HDAC inhibitor hybrids against acute myeloid leukemia cells","volume":"59","author":"Liao","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib109","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejmech.2015.10.052","article-title":"Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties","volume":"107","author":"Punganuru","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejmech.2016.09.048","article-title":"Piperlongumine (piplartine) and analogues: antiproliferative microtubule-destabilising agents","volume":"125","author":"Meegan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib111","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejmech.2014.05.070","article-title":"Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents","volume":"82","author":"Wu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib112","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.bmcl.2017.04.035","article-title":"Novel non-trimethoxylphenyl piperlongumine derivatives selectively kill cancer cells","volume":"27","author":"Zhang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113471_bib113","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejmech.2016.11.034","article-title":"Developing piperlongumine-directed glutathione S-transferase inhibitors by an electrophilicity-based strategy","volume":"126","author":"Wang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib114","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ejmech.2016.12.022","article-title":"Piperlongumine derived cyclic sulfonamides (sultams): synthesis and in\u00a0vitro exploration for therapeutic potential against HeLa cancer cell lines","volume":"126","author":"Lad","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib115","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.bmcl.2016.08.016","article-title":"Identification of novel ROS inducer by merging the fragments of piperlongumine and dicoumarol","volume":"27","author":"Xu","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113471_bib116","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejmech.2017.06.046","article-title":"Synthesis and evaluation of N-heteroaromatic ring-based analogs of piperlongumine as potent anticancer agents","volume":"138","author":"Zou","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113471_bib117","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1021\/acs.jmedchem.7b01096","article-title":"Novel ligustrazine-based analogs of piperlongumine potently suppress proliferation and metastasis of colorectal cancer cells in\u00a0vitro and in\u00a0vivo","volume":"61","author":"Zou","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib118","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1016\/j.bmcl.2018.05.025","article-title":"Piperlongumine derivative, CG-06, inhibits STAT3 activity by direct binding to STAT3 and regulating the reactive oxygen species in DU145 prostate carcinoma cells","volume":"28","author":"Kim","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113471_bib119","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.redox.2018.10.006","article-title":"A\u00a0novel platinum complex containing a piplartine derivative exhibits enhanced cytotoxicity, causes oxidative stress and triggers apoptotic cell death by ERK\/p38 pathway in human acute promyelocytic leukemia HL-60 cells","volume":"20","author":"Oliveira","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.ejmech.2021.113471_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108820","article-title":"Piperlongumine analogue L50377 induces pyroptosis via ROS mediated NF-kappa B suppression in non-small-cell lung cancer","volume":"313","author":"Li","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2021.113471_bib121","doi-asserted-by":"crossref","first-page":"112610","DOI":"10.1016\/j.ejmech.2020.112610","article-title":"Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy","author":"Qian","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib122","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1021\/acs.jnatprod.0c00599","article-title":"Piperlonguminine and piperine analogues as TrxR inhibitors that promote ROS and autophagy and regulate p38 and akt\/mTOR signaling","volume":"83","author":"Zhu","year":"2020","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113471_bib123","doi-asserted-by":"crossref","first-page":"104360","DOI":"10.1016\/j.bioorg.2020.104360","article-title":"Efficacy of novel methylenecyclohexenone derivatives as TrxR inhibitors in suppressing the proliferation and metastasis of human cancer cells","volume":"105","author":"Meng","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib124","series-title":"Novel Phenylmethylenecyclohexenone Derivatives as Potent TrxR Inhibitors Display High Antiproliferative Activity and Induce ROS, Apoptosis, and DNA Damage","first-page":"702","volume":"16","author":"Wang","year":"2021"},{"key":"10.1016\/j.ejmech.2021.113471_bib125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/jat.1261","article-title":"In\u00a0vitro and in\u00a0vivo antitumor effect of 5-FU combined with piplartine and piperine","volume":"28","author":"Bezerra","year":"2008","journal-title":"J.\u00a0Appl. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113471_bib126","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3389\/fphar.2019.01178","article-title":"Piperlongumine inhibits Akt phosphorylation to reverse resistance to cisplatin in human non-small cell lung cancer cells via ROS regulation","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113471_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/S0959-8049(14)70497-6","article-title":"Selective targeting of head and neck cancer cells by perturbing reactive oxygen species homeostasis","volume":"50","author":"Kwon","year":"2014","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113471_bib128","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.18632\/oncotarget.2402","article-title":"Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer","volume":"5","author":"Roh","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113471_bib129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cbi.2019.01.003","article-title":"Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells - the involvement of carbonyl reductase 1 inhibition","volume":"300","author":"Piska","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2021.113471_bib130","first-page":"110243","article-title":"Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells, Biomed","volume":"128","author":"Rawat","year":"2020","journal-title":"Pharma"},{"key":"10.1016\/j.ejmech.2021.113471_bib131","first-page":"386","article-title":"Piperlongumine increases the apoptotic effect of doxorubicin and paclitaxel in a cervical cancer cell line, Niger","volume":"23","author":"Seber","year":"2020","journal-title":"J.\u00a0Clin. Pract."},{"key":"10.1016\/j.ejmech.2021.113471_bib132","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-019-2212-y","article-title":"Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation","volume":"11","author":"Thatikonda","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2021.113471_bib133","series-title":"Synergistic Effects of Piperlongumine and Gemcitabine against KRAS Mutant Lung Cancer","author":"Ye","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113471_bib134","article-title":"Combined inhibition of GSH levels and sanitization of dNTPs is effective in eradicating cancer cells exposed to acute hypoxia or chronic cycling severe hypoxia","volume":"194","author":"Hansel","year":"2018","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.ejmech.2021.113471_bib135","first-page":"2525","article-title":"Effect of piperlongumine on drug resistance reversal in human retinoblastoma HXO-RB44\/VCR and SO-Rb50\/CBP cell lines","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejmech.2021.113471_bib136","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.31.1_supplement.lb526","article-title":"Exploiting ROS-generating mechanisms for IFN-g therapy of renal cell carcinoma","volume":"31","author":"Shahrokh","year":"2017","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2021.113471_bib137","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3892\/etm.2015.2254","article-title":"Piperlongumine reverses doxorubicin resistance through the PI3K\/Akt signaling pathway in K562\/A02 human leukemia cells","volume":"9","author":"Kang","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2021.113471_bib138","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1124\/dmd.108.022251","article-title":"Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver","volume":"36","author":"Kassner","year":"2008","journal-title":"Drug Metabol. Dispos.: the biological fate of chemicals"},{"key":"10.1016\/j.ejmech.2021.113471_bib139","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1039\/C3NR06599E","article-title":"Biodegradable nanoassemblies of piperlongumine display enhanced anti-angiogenesis and anti-tumor activities","volume":"6","author":"Liu","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejmech.2021.113471_bib140","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1016\/j.xphs.2017.05.027","article-title":"Coloaded nanoparticles of paclitaxel and piperlongumine for enhancing synergistic antitumor activities and reducing toxicity","volume":"106","author":"Liu","year":"2017","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.113471_bib141","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.xphs.2018.06.011","article-title":"Redox- and pH-responsive nanoparticles release piperlongumine in a stimuli-sensitive manner to inhibit pulmonary metastasis of colorectal carcinoma cells","volume":"107","author":"Lee","year":"2018","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.113471_bib142","doi-asserted-by":"crossref","first-page":"118460","DOI":"10.1016\/j.ijpharm.2019.118460","article-title":"Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting","volume":"567","author":"Carvalho","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2021.113471_bib143","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1055\/a-0614-2680","article-title":"Leishmanicidal effects of piperlongumine (piplartine) and its putative metabolites","volume":"84","author":"Moreira","year":"2018","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2021.113471_bib144","doi-asserted-by":"crossref","first-page":"105350","DOI":"10.1016\/j.actatropica.2020.105350","article-title":"Antiparasitic activity of piplartine (piperlongumine) in a mouse model of schistosomiasis","volume":"205","author":"Mengarda","year":"2020","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2021.113471_bib145","article-title":"Eudesmol isomers induce caspase-mediated apoptosis in human hepatocellular carcinoma HepG2 cells","volume":"49","author":"Bomfim","year":"2013","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113471_bib146","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0031-9422(00)00226-0","article-title":"Antifungal amides from Piper hispidum and Piper tuberculatum","volume":"55","author":"Navickiene","year":"2000","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2021.113471_bib147","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0031-9422(01)00431-9","article-title":"Antifungal amides from Piper arboreum and Piper tuberculatum","volume":"59","author":"Vasques da Silva","year":"2002","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2021.113471_bib148","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1055\/a-0614-2680","article-title":"Leishmanicidal effects of piperlongumine (piplartine) and its putative metabolites","volume":"84","author":"Moreira","year":"2018","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2021.113471_bib149","article-title":"Alkaloid-rich crude extracts, fractions and piperamide alkaloids of piper guineense possess promising antibacterial effects","volume":"7","author":"Mgbeahuruike","year":"2018","journal-title":"Antibiotics-Basel"},{"key":"10.1016\/j.ejmech.2021.113471_bib150","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1248\/cpb.49.830","article-title":"Structure-activity relationships of N-(3,5-dimethoxy-4-n-octyloxycinnamoyl)-N\u2019-(3,4-dimethylphenyl)piperazine and analogues as inhibitors of acyl-CoA: cholesterol O-acyltransferase","volume":"49","author":"Ohishi","year":"2001","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2021.113471_bib151","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/toxsci\/64.2.259","article-title":"Sex-dependent toxicity of a novel acyl-CoA:cholesterol acyltransferase inhibitor, YIC-C8-434, in relation to sex-specific forms of cytochrome P450 in rats","volume":"64","author":"Kaneko","year":"2001","journal-title":"Toxicol. Sci. : an official journal of the Society of Toxicology"},{"key":"10.1016\/j.ejmech.2021.113471_bib152","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1128\/AAC.01558-15","article-title":"A\u00a0novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formation","volume":"59","author":"Wang","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113471_bib153","doi-asserted-by":"crossref","DOI":"10.1186\/s13765-019-0471-z","article-title":"Naturally occurring Piper plant amides potential in agricultural and pharmaceutical industries: perspectives of piperine and piperlongumine","author":"Jeon","year":"2019","journal-title":"Appl. Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib154","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejmech.2019.04.009","article-title":"Research progress in the biological activities of 3,4,5-trimethoxycinnamic acid (TMCA) derivatives","volume":"173","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113471_bib155","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3389\/fimmu.2020.01172","article-title":"Piperlongumine acts as an immunosuppressant by exerting prooxidative effects in human T cells resulting in diminished TH17 but enhanced treg differentiation","volume":"11","author":"Liang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2021.113471_bib156","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/15548627.2017.1390636","article-title":"Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models","volume":"14","author":"Liu","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2021.113471_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151707","article-title":"Preformulation studies on piperlongumine","volume":"11","author":"Aodah","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113471_bib158","first-page":"7","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2021.113471_bib159","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","article-title":"The thioredoxin antioxidant system","volume":"66","author":"Lu","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113471_bib160","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1021\/np50072a030","article-title":"Cytotoxic pyridone alkaloids from the leaves of Piper aborescens","volume":"53","author":"Duh","year":"1990","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113471_bib161","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2013.01.017","article-title":"Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells","volume":"431","author":"Jarvius","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113471_bib162","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1248\/bpb.33.912","article-title":"Biomimetic oxidation of piperine and piplartine catalyzed by iron(III) and manganese(III) porphyrins, Bio","volume":"33","author":"Schaab","year":"2010","journal-title":"Pharm. Bull."},{"key":"10.1016\/j.ejmech.2021.113471_bib163","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.freeradbiomed.2015.12.008","article-title":"Enhanced targeting of mitochondrial peroxide defense by the combined use of thiosemicarbazones and inhibitors of thioredoxin reductase","volume":"91","author":"Myers","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113471_bib164","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.phrs.2015.06.013","article-title":"Mitochondrial ROS and cancer drug resistance: implications for therapy","volume":"100","author":"Okon","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2021.113471_bib165","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1038\/emm.2016.119","article-title":"ROS homeostasis and metabolism: a critical liaison for cancer therapy","volume":"48","author":"Kim","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113471_bib166","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s11671-019-2887-0","article-title":"Piperlongumine-eluting gastrointestinal stent using reactive oxygen species-sensitive nanofiber mats for inhibition of cholangiocarcinoma cells","volume":"14","author":"Jang","year":"2019","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.ejmech.2021.113471_bib167","article-title":"The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway","volume":"19","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113471_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184413","article-title":"Immune and inflammatory cells in thyroid cancer microenvironment","volume":"20","author":"Ferrari","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113471_bib169","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ejmech.2021.113471_bib170","first-page":"766","article-title":"Cancer drug development in China: recent advances and future challenges, Drug Discov","volume":"20","author":"Wu","year":"2015","journal-title":"Today Off."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:30:00Z","timestamp":1759329000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421003202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":170,"alternative-id":["S0223523421003202"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113471","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of piperlongumine analogues and their therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113471"}}